Predictive and prognostic value of v-set and transmembrane domain-containing 1 expression in monocytes for coronary artery disease.

The aim of this study was to investigate the correlation between v-set and transmembrane domain-containing 1 (VSTM1) expression and incidence of major adverse cardiac events (MACE) in patients with coronary heart disease (CHD). A total of 310 patients were divided into a non-acute coronary syndrome (non-ACS) group (containing the stable angina group, and the asymptomatic coronary artery diseaseand other patients group) and an ACS group (containing unstable angina and acute myocardial infarction patients). Monocytic VSTM1 expression levels (assessed via average fluorescence intensity derived from antibody binding to VSTM1) in each group were detected and analyzed. The cut-off value of monocytic VSTM1 expression to predict the onset of ACS and MACE was confirmed. VSTM1 expression in monocytes from the ACS group was lower than that of the non-ACS group. The incidence of MACEs in the high VSTM1-expression group was much less than that of those in the low VSTM1 expression group at the 1 year follow-up stage. VSTM1 expression had an independent-inversed association with increased incidence of MACE and ACS. VSTM1 expression in monocytes may help to predict the occurrence of ACS in patients with CHD, and moreover it may provide the means to evaluate MACE prognosis during CHD patient follow-up.

[1]  Changqian Wang,et al.  Nicotine exacerbates atherosclerosis through a macrophage-mediated endothelial injury pathway , 2021, Aging.

[2]  B. Oldenburg,et al.  Signal Inhibitory Receptor on Leukocytes-1 is highly expressed on lung monocytes, but absent on mononuclear phagocytes in skin and colon. , 2020, Cellular immunology.

[3]  F. Crea,et al.  Atherosclerotic Plaque Healing. , 2020, The New England journal of medicine.

[4]  Hang Lee,et al.  Predictors of Rapid Plaque Progression: An Optical Coherence Tomography Study. , 2020, JACC. Cardiovascular imaging.

[5]  L. Räber,et al.  In vivo relationship between near-infrared spectroscopy-detected lipid-rich plaques and morphological plaque characteristics by optical coherence tomography and intravascular ultrasound: a multimodality intravascular imaging study. , 2020, European heart journal cardiovascular Imaging.

[6]  M. Hennus,et al.  Signal inhibitory receptor on leukocytes (SIRL)-1 and leukocyte- associated immunoglobulin-like receptor (LAIR)-1 regulate neutrophil function in infants. , 2019, Clinical immunology.

[7]  Nicolas F. Fernandez,et al.  Single-cell immune landscape of human atherosclerotic plaques , 2019, Nature Medicine.

[8]  P. Libby,et al.  Na+-H+ exchanger 1 determines atherosclerotic lesion acidification and promotes atherogenesis , 2019, Nature Communications.

[9]  Marco Valgimigli,et al.  2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. , 2019, European heart journal.

[10]  Ira Tabas,et al.  Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities , 2019, Nature Reviews Cardiology.

[11]  G. Vriend,et al.  Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis , 2018, Journal of the American College of Cardiology.

[12]  Marco Valgimigli,et al.  [2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.] , 2018, Kardiologia polska.

[13]  M. Jarvelin,et al.  A functional SNP associated with atopic dermatitis controls cell type-specific methylation of the VSTM1 gene locus , 2017, Genome Medicine.

[14]  K. Bornfeldt,et al.  Macrophage Phenotype and Function in Different Stages of Atherosclerosis. , 2016, Circulation research.

[15]  M. Bennett,et al.  Vascular Smooth Muscle Cells in Atherosclerosis. , 2016, Circulation research.

[16]  G. Niccoli,et al.  Advances in mechanisms, imaging and management of the unstable plaque. , 2014, Atherosclerosis.

[17]  R. Fritsch-Stork,et al.  Ligation of Signal Inhibitory Receptor on Leukocytes-1 Suppresses the Release of Neutrophil Extracellular Traps in Systemic Lupus Erythematosus , 2013, PloS one.

[18]  K. Moore,et al.  Macrophages in atherosclerosis: a dynamic balance , 2013, Nature Reviews Immunology.

[19]  P. Coffer,et al.  Signal inhibitory receptor on leukocytes‐1 (SIRL‐1) negatively regulates the oxidative burst in human phagocytes , 2013, European journal of immunology.

[20]  Ting Li,et al.  VSTM1-v2, a novel soluble glycoprotein, promotes the differentiation and activation of Th17 cells. , 2012, Cellular immunology.

[21]  T. Akasaka,et al.  Diverse Roles of Macrophages in Atherosclerosis: From Inflammatory Biology to Biomarker Discovery , 2012, Mediators of inflammation.

[22]  Jeroen J. Bax,et al.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.

[23]  C. Weber,et al.  Atherosclerosis: current pathogenesis and therapeutic options , 2011, Nature Medicine.

[24]  P. Coffer,et al.  Signal Inhibitory Receptor on Leukocytes-1 Is a Novel Functional Inhibitory Immune Receptor Expressed on Human Phagocytes , 2010, The Journal of Immunology.

[25]  Brett E. Bouma,et al.  In vivo association between positive coronary artery remodelling and coronary plaque characteristics assessed by intravascular optical coherence tomography. , 2008, European heart journal.

[26]  Nichola Figg,et al.  Monocyte/Macrophage Suppression in CD11b Diphtheria Toxin Receptor Transgenic Mice Differentially Affects Atherogenesis and Established Plaques , 2007, Circulation research.

[27]  R. Virmani,et al.  Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. , 1996, Circulation.

[28]  J. Hewitt,et al.  The role of lipids and lipoproteins in atherosclerosis. , 1950, Science.